Photo Rounds

Adolescent with rash on face and scalp

Author and Disclosure Information

 

References

Antifungals are the mainstay of treatment

Because there is no cure for SD, the goal of therapy is to control the dermatitis. Topical antifungal agents are used to suppress the Malassezia yeast and topical steroids are used to suppress inflammation. Azole antifungal medications such as ketoconazole are effective and can be used for long periods of time with minimal risk of adverse effects3-5 (strength of recommendation [SOR]: C).

Our patient had used nystatin cream, which is effective against Candida yeast infections, but not especially effective for Malassezia sp.6

To reduce inflammation, mild topical steroids such as hydrocortisone cream 2.5% should be used. However, they must be used for short periods to avoid atrophy, telangiectasias, and steroid-induced acne. An alternative evolving treatment is to use a calcineurin inhibitor, such as pimecrolimus cream 1% or tacrolimus ointment 0.1%. These drugs do not exacerbate hypopigmentation, an effect that sometimes is attributed to topical steroids.7

Scalp treatments include shampoos such as ketoconazole 2%, selenium sulfide 2.5%, and ciclopirox 1%.3 Shampoos should be lathered up and left on the scalp for 3 to 5 minutes before rinsing.

Two forms of ketoconazole for our patient

Our patient responded well to ketoconazole cream 2% applied twice daily to the face and other areas without hair and ketoconazole 2% shampoo twice weekly. At a 6-week follow-up, the patient had significant improvement in scaling and pruritus on the central face and scalp. The associated facial hypopigmentation faded over 3 months.

CORRESPONDENCE
Robert T. Brodell MD, Division of Dermatology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216; rbrodell@umc.edu

Pages

Recommended Reading

VIDEO: Ivermectin shows promise for treating papulopustular rosacea
MDedge Family Medicine
Novel agent for papulopustular rosacea found safe, effective in phase III trials
MDedge Family Medicine
Tofacitinib found noninferior to etanercept for treating psoriasis
MDedge Family Medicine
Psoriatic pruritus improves with TrkA-blocking drug
MDedge Family Medicine
VIDEO: Battlefield lessons improve treatment of traumatic scars
MDedge Family Medicine
Melanomas were less invasive at diagnosis in patients with established dermatologist
MDedge Family Medicine
Childhood rosacea may wear acne mask
MDedge Family Medicine
What’s old is new again for actinic keratoses treatment
MDedge Family Medicine
FDA panel endorses antibacterial dalbavancin
MDedge Family Medicine
Key studies show distinctive features of pediatric psoriasis
MDedge Family Medicine